Listed

Neogenomics Inc

NEONasdaqCIK 1077183IndustrialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$201.7m, Q2 FY2026
Operating income−$9.8m, Q2 FY2026
Net income$2.2m, Q2 FY2026
Neogenomics Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m152Revenue, Q3 FY2023, three months to 2023-09-30$152.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure156Revenue, Q4 FY2023, three months to 2023-12-31$155.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure156Revenue, Q1 FY2024, three months to 2024-03-31$156.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure165Revenue, Q2 FY2024, three months to 2024-06-30$164.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure168Revenue, Q3 FY2024, three months to 2024-09-30$167.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure172Revenue, Q4 FY2024, three months to 2024-12-31$172.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure168Revenue, Q1 FY2025, three months to 2025-03-31$168.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure181Revenue, Q2 FY2025, three months to 2025-06-30$181.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure188Revenue, Q3 FY2025, three months to 2025-09-30$187.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure190Revenue, Q4 FY2025, three months to 2025-12-31$190.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure187Revenue, Q1 FY2026, three months to 2026-03-31$186.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure202Revenue, Q2 FY2026, three months to 2026-06-30$201.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Cost of revenue$m89.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$89.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure88.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$88.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure90.8Cost of revenue, Q1 FY2024, three months to 2024-03-31$90.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure92.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$92.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure92.9Cost of revenue, Q3 FY2024, three months to 2024-09-30$92.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure94.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$94.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure94.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$94.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure104Cost of revenue, Q2 FY2025, three months to 2025-06-30$104.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure107Cost of revenue, Q3 FY2025, three months to 2025-09-30$107.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure107Cost of revenue, Q4 FY2025, three months to 2025-12-31$106.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure106Cost of revenue, Q1 FY2026, three months to 2026-03-31$105.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure110Cost of revenue, Q2 FY2026, three months to 2026-06-30$109.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Gross profit$m62.3Gross profit, Q3 FY2023, three months to 2023-09-30$62.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure67.6Gross profit, Q4 FY2023, three months to 2023-12-31$67.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure65.5Gross profit, Q1 FY2024, three months to 2024-03-31$65.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure72.5Gross profit, Q2 FY2024, three months to 2024-06-30$72.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure74.9Gross profit, Q3 FY2024, three months to 2024-09-30$74.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure77.3Gross profit, Q4 FY2024, three months to 2024-12-31$77.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure73.2Gross profit, Q1 FY2025, three months to 2025-03-31$73.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure77.3Gross profit, Q2 FY2025, three months to 2025-06-30$77.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure80.4Gross profit, Q3 FY2025, three months to 2025-09-30$80.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure83.3Gross profit, Q4 FY2025, three months to 2025-12-31$83.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure80.9Gross profit, Q1 FY2026, three months to 2026-03-31$80.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure91.9Gross profit, Q2 FY2026, three months to 2026-06-30$91.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Research and development$m5.3Research and development, Q3 FY2023, three months to 2023-09-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure7.1Research and development, Q4 FY2023, three months to 2023-12-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure7.6Research and development, Q1 FY2024, three months to 2024-03-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure7.9Research and development, Q2 FY2024, three months to 2024-06-30$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure7.7Research and development, Q3 FY2024, three months to 2024-09-30$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure8.0Research and development, Q4 FY2024, three months to 2024-12-31$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure10.2Research and development, Q1 FY2025, three months to 2025-03-31$10.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure9.0Research and development, Q2 FY2025, three months to 2025-06-30$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure8.7Research and development, Q3 FY2025, three months to 2025-09-30$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure9.2Research and development, Q4 FY2025, three months to 2025-12-31$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure9.5Research and development, Q1 FY2026, three months to 2026-03-31$9.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure10.8Research and development, Q2 FY2026, three months to 2026-06-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Operating income$m(24.2)Operating income, Q3 FY2023, three months to 2023-09-30−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure(18.6)Operating income, Q4 FY2023, three months to 2023-12-31−$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(30.6)Operating income, Q1 FY2024, three months to 2024-03-31−$30.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure(21.9)Operating income, Q2 FY2024, three months to 2024-06-30−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure(21.2)Operating income, Q3 FY2024, three months to 2024-09-30−$21.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(18.4)Operating income, Q4 FY2024, three months to 2024-12-31−$18.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(27.8)Operating income, Q1 FY2025, three months to 2025-03-31−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure(47.6)Operating income, Q2 FY2025, three months to 2025-06-30−$47.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure(27.0)Operating income, Q3 FY2025, three months to 2025-09-30−$27.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(13.4)Operating income, Q4 FY2025, three months to 2025-12-31−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(18.2)Operating income, Q1 FY2026, three months to 2026-03-31−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure(9.8)Operating income, Q2 FY2026, three months to 2026-06-30−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Interest expense$m(2.8)Interest expense, Q3 FY2023, three months to 2023-09-30−$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure13.7Interest expense, Q4 FY2023, three months to 2023-12-31$13.7m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-20, accession 0001077183-24-000011. Derived: 12-month figure less the 9-month figure.Report this figure1.7Interest expense, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure1.7Interest expense, Q2 FY2024, three months to 2024-06-30$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure1.6Interest expense, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure1.6Interest expense, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1.6Interest expense, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure0.9Interest expense, Q2 FY2025, three months to 2025-06-30$933.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure0.6Interest expense, Q3 FY2025, three months to 2025-09-30$603.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure0.6Interest expense, Q4 FY2025, three months to 2025-12-31$599.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2026, three months to 2026-03-31$598.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure0.8Interest expense, Q2 FY2026, three months to 2026-06-30$781.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Income tax$m(2.9)Income tax, Q3 FY2023, three months to 2023-09-30−$2.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure(1.0)Income tax, Q4 FY2023, three months to 2023-12-31−$960.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(0.6)Income tax, Q1 FY2024, three months to 2024-03-31−$620.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure(0.4)Income tax, Q2 FY2024, three months to 2024-06-30−$375.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure(0.2)Income tax, Q3 FY2024, three months to 2024-09-30−$150.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(0.8)Income tax, Q4 FY2024, three months to 2024-12-31−$804.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2025, three months to 2025-03-31$266.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure(0.7)Income tax, Q2 FY2025, three months to 2025-06-30−$724.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure0.7Income tax, Q3 FY2025, three months to 2025-09-30$740.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(2.5)Income tax, Q4 FY2025, three months to 2025-12-31−$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Income tax, Q1 FY2026, three months to 2026-03-31−$472.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure(0.4)Income tax, Q2 FY2026, three months to 2026-06-30−$412.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Net income$m(18.5)Net income, Q3 FY2023, three months to 2023-09-30−$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure(14.3)Net income, Q4 FY2023, three months to 2023-12-31−$14.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(27.1)Net income, Q1 FY2024, three months to 2024-03-31−$27.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(18.6)Net income, Q2 FY2024, three months to 2024-06-30−$18.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(17.7)Net income, Q3 FY2024, three months to 2024-09-30−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(15.3)Net income, Q4 FY2024, three months to 2024-12-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(25.9)Net income, Q1 FY2025, three months to 2025-03-31−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure(45.1)Net income, Q2 FY2025, three months to 2025-06-30−$45.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure(27.1)Net income, Q3 FY2025, three months to 2025-09-30−$27.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure(9.9)Net income, Q4 FY2025, three months to 2025-12-31−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(17.1)Net income, Q1 FY2026, three months to 2026-03-31−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure2.2Net income, Q2 FY2026, three months to 2026-06-30$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Balance sheet

Cash and equivalents$145.5m, Q2 FY2026
Long-term debt$374.2m, Q2 FY2026
Shareholders' equity$785.7m, Q2 FY2026
Neogenomics Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m306Cash and equivalents, Q3 FY2023, at 2023-09-30$306.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure342Cash and equivalents, FY2023, at 2023-12-31$342.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figure332Cash and equivalents, Q1 FY2024, at 2024-03-31$331.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure355Cash and equivalents, Q2 FY2024, at 2024-06-30$355.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-30, accession 0001077183-24-000109.Report this figure362Cash and equivalents, Q3 FY2024, at 2024-09-30$362.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure367Cash and equivalents, FY2024, at 2024-12-31$367.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figure346Cash and equivalents, Q1 FY2025, at 2025-03-31$346.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure155Cash and equivalents, Q2 FY2025, at 2025-06-30$154.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure164Cash and equivalents, Q3 FY2025, at 2025-09-30$164.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure160Cash and equivalents, FY2025, at 2025-12-31$159.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure146Cash and equivalents, Q1 FY2026, at 2026-03-31$146.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure146Cash and equivalents, Q2 FY2026, at 2026-06-30$145.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Current assets$m587Current assets, Q3 FY2023, at 2023-09-30$587.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure597Current assets, FY2023, at 2023-12-31$596.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figure574Current assets, Q1 FY2024, at 2024-03-31$573.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure584Current assets, Q2 FY2024, at 2024-06-30$584.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-30, accession 0001077183-24-000109.Report this figure590Current assets, Q3 FY2024, at 2024-09-30$590.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure596Current assets, FY2024, at 2024-12-31$596.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figure574Current assets, Q1 FY2025, at 2025-03-31$573.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure393Current assets, Q2 FY2025, at 2025-06-30$392.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure382Current assets, Q3 FY2025, at 2025-09-30$382.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure376Current assets, FY2025, at 2025-12-31$376.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure374Current assets, Q1 FY2026, at 2026-03-31$373.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure381Current assets, Q2 FY2026, at 2026-06-30$381.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Total assets$m1,678Total assets, Q3 FY2023, at 2023-09-30$1.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure1,681Total assets, FY2023, at 2023-12-31$1.68bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figure1,640Total assets, Q1 FY2024, at 2024-03-31$1.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure1,643Total assets, Q2 FY2024, at 2024-06-30$1.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-30, accession 0001077183-24-000109.Report this figure1,641Total assets, Q3 FY2024, at 2024-09-30$1.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure1,638Total assets, FY2024, at 2024-12-31$1.64bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figure1,601Total assets, Q1 FY2025, at 2025-03-31$1.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure1,394Total assets, Q2 FY2025, at 2025-06-30$1.39bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure1,375Total assets, Q3 FY2025, at 2025-09-30$1.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure1,360Total assets, FY2025, at 2025-12-31$1.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure1,347Total assets, Q1 FY2026, at 2026-03-31$1.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure1,352Total assets, Q2 FY2026, at 2026-06-30$1.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Current liabilities$m92.9Current liabilities, Q3 FY2023, at 2023-09-30$92.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure96.3Current liabilities, FY2023, at 2023-12-31$96.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figure76.7Current liabilities, Q1 FY2024, at 2024-03-31$76.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure290Current liabilities, Q2 FY2024, at 2024-06-30$290.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-30, accession 0001077183-24-000109.Report this figure296Current liabilities, Q3 FY2024, at 2024-09-30$296.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure301Current liabilities, FY2024, at 2024-12-31$301.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figure280Current liabilities, Q1 FY2025, at 2025-03-31$279.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure100Current liabilities, Q2 FY2025, at 2025-06-30$100.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure97.9Current liabilities, Q3 FY2025, at 2025-09-30$97.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure88.3Current liabilities, FY2025, at 2025-12-31$88.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure84.6Current liabilities, Q1 FY2026, at 2026-03-31$84.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure106Current liabilities, Q2 FY2026, at 2026-06-30$105.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Total liabilities$m731Total liabilities, Q3 FY2023, at 2023-09-30$730.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure740Total liabilities, FY2023, at 2023-12-31$739.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figure717Total liabilities, Q1 FY2024, at 2024-03-31$716.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure727Total liabilities, Q2 FY2024, at 2024-06-30$727.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-30, accession 0001077183-24-000109.Report this figure733Total liabilities, Q3 FY2024, at 2024-09-30$732.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure736Total liabilities, FY2024, at 2024-12-31$735.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figure713Total liabilities, Q1 FY2025, at 2025-03-31$713.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure540Total liabilities, Q2 FY2025, at 2025-06-30$539.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure536Total liabilities, Q3 FY2025, at 2025-09-30$536.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure523Total liabilities, FY2025, at 2025-12-31$523.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure518Total liabilities, Q1 FY2026, at 2026-03-31$517.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure567Total liabilities, Q2 FY2026, at 2026-06-30$566.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Long-term debt$mnot reported538Long-term debt, FY2023, at 2023-12-31$538.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figurenot reportednot reportednot reported340Long-term debt, FY2024, at 2024-12-31$340.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figurenot reportednot reportednot reported342Long-term debt, FY2025, at 2025-12-31$341.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figurenot reported374Long-term debt, Q2 FY2026, at 2026-06-30$374.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported201Current portion of debt, FY2024, at 2024-12-31$200.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-18, accession 0001077183-25-000028.Report this figurenot reportednot reportednot reported0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figurenot reportednot reported
Shareholders' equity$m947Shareholders' equity, Q3 FY2023, at 2023-09-30$947.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure942Shareholders' equity, FY2023, at 2023-12-31$941.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0001077183-26-000010.Report this figure923Shareholders' equity, Q1 FY2024, at 2024-03-31$923.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure916Shareholders' equity, Q2 FY2024, at 2024-06-30$915.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure908Shareholders' equity, Q3 FY2024, at 2024-09-30$908.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure902Shareholders' equity, FY2024, at 2024-12-31$902.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure888Shareholders' equity, Q1 FY2025, at 2025-03-31$888.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure854Shareholders' equity, Q2 FY2025, at 2025-06-30$854.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure838Shareholders' equity, Q3 FY2025, at 2025-09-30$838.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure837Shareholders' equity, FY2025, at 2025-12-31$836.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure829Shareholders' equity, Q1 FY2026, at 2026-03-31$828.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure786Shareholders' equity, Q2 FY2026, at 2026-06-30$785.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure

Cash flow

Operating cash flow$20.0m, Q2 FY2026
Capital expenditure$8.2m, Q2 FY2026
Neogenomics Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(5.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001077183-24-000157. Derived: 9-month figure less the 6-month figure.Report this figure17.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$17.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(25.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$25.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure13.9Operating cash flow, Q2 FY2024, three months to 2024-06-30$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-29, accession 0001077183-25-000154. Derived: 6-month figure less the 3-month figure.Report this figure9.2Operating cash flow, Q3 FY2024, three months to 2024-09-30$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001077183-25-000175. Derived: 9-month figure less the 6-month figure.Report this figure9.8Operating cash flow, Q4 FY2024, three months to 2024-12-31$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(25.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$25.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure20.3Operating cash flow, Q2 FY2025, three months to 2025-06-30$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-28, accession 0001077183-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure8.9Operating cash flow, Q3 FY2025, three months to 2025-09-30$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001077183-25-000175. Derived: 9-month figure less the 6-month figure.Report this figure1.3Operating cash flow, Q4 FY2025, three months to 2025-12-31$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure20.0Operating cash flow, Q2 FY2026, three months to 2026-06-30$20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-28, accession 0001077183-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m4.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$4.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001077183-24-000157. Derived: 9-month figure less the 6-month figure.Report this figure7.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$7.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure5.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure13.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$13.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-29, accession 0001077183-25-000154. Derived: 6-month figure less the 3-month figure.Report this figure10.8Capital expenditure, Q3 FY2024, three months to 2024-09-30$10.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001077183-25-000175. Derived: 9-month figure less the 6-month figure.Report this figure11.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$11.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure4.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure6.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$6.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-28, accession 0001077183-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure8.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$8.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001077183-25-000175. Derived: 9-month figure less the 6-month figure.Report this figure7.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$7.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001077183-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure5.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure8.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$8.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-28, accession 0001077183-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)130.83m, Q2 FY2026
Neogenomics Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares124Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30124,425,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001077183-23-000138.Report this figure125Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31125,026,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-30, accession 0001077183-24-000054.Report this figure125Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30125,356,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-30, accession 0001077183-24-000109.Report this figure126Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30125,687,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001077183-24-000157.Report this figure126Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31126,111,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-29, accession 0001077183-25-000076.Report this figure126Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30126,405,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-29, accession 0001077183-25-000154.Report this figure127Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30126,953,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure127Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31127,376,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure128Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30127,949,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure128Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30128,415,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001077183-25-000175.Report this figure129Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31129,166,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001077183-26-000023.Report this figure131Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30130,831,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure

Shares outstanding: 128.48mShares outstanding, period not labelled, at 2026-07-24128,475,440 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-28, accession 0001077183-26-000059.Report this figure at Jul 24, 2026, from the cover of the 10-Q filed Jul 28, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.